Home/Insiders/FARRELL PETER C
FP
SEC Insider//CIK 0001186102

FARRELL PETER C

CIK 00011861025 companiesSAN DIEGO, CA

Transactions

50

Companies

5

Filings

17

CIK

0001186102

Recent Transactions

50 trades
  • Sale

    ResMed Common Stock

    2026-01-07$248.83/sh2,00066,773 total
  • Sale

    ResMed Common Stock

    2025-12-03$251.47/sh2,00068,773 total
  • Award

    ResMed Common Stock Options

    2025-11-24$250.52/sh+1,3311,331 total
  • Award

    ResMed Common Stock

    2025-11-20+53670,773 total
  • Tax Payment

    ResMed Common Stock

    2025-11-14$244.46/sh7,31470,238 total
  • Exercise/Conversion

    ResMed Common Stock Options

    2025-11-1411,4420 total
  • Exercise/Conversion

    ResMed Common Stock

    2025-11-14$101.64/sh+11,44277,552 total
  • Sale

    ResMed Common Stock

    2025-11-12$252.05/sh2,00066,110 total
  • Tax Payment

    ResMed Common Stock

    2025-11-11$250.10/sh162.95368,110 total
  • Sale

    ResMed Common Stock

    2025-07-02$255.49/sh94568,273 total
  • Award

    Stock option (right to buy)

    2025-06-09+15,00015,000 total
  • Sale

    ResMed Common Stock

    2025-06-04$247.32/sh2,00069,218 total
  • Sale

    ResMed Common Stock

    2025-05-07$242.25/sh2,00071,218 total
  • Sale

    ResMed Common Stock

    2025-04-02$219.74/sh2,00073,218 total
  • Sale

    ResMed Common Stock

    2025-03-05$227.71/sh2,00075,218 total
  • Sale

    ResMed Common Stock

    2025-02-05$242.11/sh2,00077,218 total
  • Sale

    ResMed Common Stock

    2025-01-02$230.99/sh2,00079,218 total
  • Sale

    ResMed Common Stock

    2024-12-04$245.65/sh2,00081,218 total
  • Award

    ResMed Common Stock Options

    2024-11-25$249.56/sh+1,4681,468 total
  • Award

    ResMed Common Stock

    2024-11-20+54283,218 total
  • Tax Payment

    ResMed Common Stock

    2024-11-11$252.38/sh527.90582,676 total
  • Sale

    ResMed Common Stock

    2024-11-06$248.74/sh2,00083,204 total
  • Sale

    ResMed Common Stock

    2024-10-02$237.20/sh2,00085,204 total
  • Sale

    ResMed Common Stock

    2024-09-04$239.90/sh2,00087,204 total
  • Award

    Stock option (right to buy)

    2024-06-14+15,00015,000 total
  • Exercise/Conversion

    Deferred Stock Units

    2024-06-143,1310 total
  • Exercise/Conversion

    Common Stock

    2024-06-14+3,13155,741 total
  • Gift

    ResMed Common Stock

    2024-05-1568,20089,204 total
  • Sale

    ResMed Common Stock

    2024-02-22$182.66/sh10,935157,404 total
  • Award

    ResMed Common Stock

    2023-11-16+1,768180,939 total
  • Tax Payment

    ResMed Common Stock

    2023-11-13$143.60/sh325.375179,171 total
  • Award

    Stock option (right to buy)

    2023-08-01+11,86911,869 total
  • Award

    Deferred Stock Units

    2023-08-01+3,1313,131 total
  • Sale

    ResMed Common Stock

    2023-05-03$237.17/sh12,600166,896 total
  • Award

    Common Stock

    2023-01-27+8,29343,174 total
  • Award

    Stock Option (Right to Buy)

    2023-01-27+11,78911,789 total
  • Award

    ResMed Common Stock

    2022-11-16+1,122179,496 total
  • Tax Payment

    ResMed Common Stock

    2022-11-11$225.18/sh128178,374 total
  • Sale

    ResMed Common Stock

    2022-10-31$221.98/sh9,050183,052 total
  • Gift

    ResMed Common Stock

    2022-10-314,550178,502 total
  • Purchase

    Common Stock

    2022-09-06$9.10/sh+10,00010,000 total
  • Award

    Stock Option (right to buy)

    2022-06-23+15,00015,000 total
  • Award

    Stock Option (Right to Buy)

    2022-01-24+22,72722,727 total
  • Award

    Common Stock

    2022-01-24+15,56834,881 total
  • Award

    ResMed Common Stock

    2021-11-18+478192,102 total
  • Award

    ResMed Common Stock Options

    2021-11-18+1,6951,695 total
  • Tax Payment

    ResMed Common Stock

    2021-11-11$259.47/sh342191,624 total
  • Gift

    ResMed Common Stock

    2021-08-1336,670191,966 total
  • Award

    Stock Option (right to buy)

    2021-06-18+15,00015,000 total
  • Award

    Common Stock

    2021-02-05+19,31319,313 total